Management Forum courses now available at IPI Academy - visit IPI for an updated experience and a broader selection of courses and subjects

Dry Powder Inhalers Training Course

A comprehensive overview of DPIs including market trends, treatments formulation, regulation and device design.


Conference overview

The global dry powder inhaler (DPI) market is expected to grow at a robust rate over the next few years. The growing prevalence worldwide of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) is one of the major factors fuelling this growth with a rising demand for advance healthcare devices for the treatment of these chronic diseases.

This annual two-day seminar will provide a comprehensive review of all the key aspects of DPIs including therapeutic targets, the latest delivery technologies and the current regulatory landscape. Participants will gain a valuable insight into market potential, respiratory diseases and key treatment guidelines, formulation, stability testing, characterisation studies, device design, human factors, quality by design (QbD) and the manufacturing process. Intellectual property, bioequivalence and the opportunities of connectivity with DPIs will also be addressed.
This must-attend event will include practical workshop sessions and provide a unique opportunity to discuss DPIs with fellow professionals and our expert faculty of speakers who all have significant expertise in this field.

Benefits of attending:
  • Know the market potential
  • Clarify the therapeutic targets
  • Gain an insight into delivery technologies
  • Consider key treatment guidelines
  • Understand the formulation challenges
  • Discuss essential aspects of DPI QbD medicine development
  • Obtain key information on device design and human factors
  • Know the regulatory pathways to follow
  • Consider bioquivalence (in-vitro vs in-vivo)
  • Consolidate learning with interactive workshops and discussion sessions

Media Partners



Who should attend

This event will be beneficial to all those new to the area and those who require a refresher on the opportunities and challenges with this technology. The content will appeal to pharmaceutical scientists, formulation scientists and analysts, device designers and specialists in industrialisation, quality assurance and regulatory affairs who may want to gain an understanding of both the history of and current practices in DPI development and manufacture in the pharmaceutical industry. It will be of benefit to individuals with an interest both in innovative and generic products and the associated international regulatory expectations associated with DPI products.

Professionals from associated industries such as primary packing suppliers, excipient (used in DPIs) producers, DPI equipment designers and manufacturers for unit processes who wish to understand the scope of DPI respiratory medicine development will also find this seminar useful.

Media partners and exhibitors


Media partners




Book now

Book now

We do not currently have dates confirmed for this course; please contact us to be informed when it is scheduled; or to discuss running this course on an in-house basis for your staff.

Continuing professional development

This course qualifies for 12 hours for your CPD records.
More about CPD

Customised in-house training

We can customise this course to meet the requirements of your organisation and deliver it at your location and/or online.

Contact us

Previous customers include...

  • 3M Health Care Ltd
  • Actavis Inc
  • Alchemy Pharmatech
  • AstraZeneca AB
  • Bang & Olufsen Medicom AS
  • Bayer Pharma AG
  • Bespak Europe Ltd
  • Bio Products Laboratory
  • Breathe Pharmaceuticals
  • Chemo Group
  • Chiesi Limited
  • Innovata Ltd (part of Vectura Group plc)
  • Job Consultoria
  • Laboratoires SMB S.A.
  • MEDA Pharam GmbH & Co KG
  • PA Consulting
  • Recipharm Publ Ab
  • Respivert Ltd
  • Sanofi-Aventis
  • Steve Harris Associates
  • University of Groningen
  • University of Warwick
  • XSpray Microparticles AB
  • Zentiva Inhalationsprodukte GmbH

Very good organisation, time keeping, very valuable information delivered by speakers.

Waldemar Wiśniewski, Project Manager, Pulinno sp. z o.o., Jun 18

Well selected speakers, covering broad range.

Steffen Fredersdorf, Manager Clinical Program, Philip Morris International, Jun 18

Interesting, helpful, nice examples, informative! Offers good overview on DPI's. Many thanks!

Ina Brueckner, CMC Manager Medical Devices, Bayer Pharma AG, Jun 18

Thanks all of them, they share their valuable experience. All of the speakers are valuable people, they are the best in their jobs. Conference met my expectation.

Emre Kisasoz, Arven, Jun 18

I really thought it as well organised with good content, length of presentations and quality of speakers.

Mahmoud Farag, Scientific Business Development Manager, Qualicaps , Jun 17

In general, the course was very interesting and well organized

Berta Fernández Mollar, Senior Formulation Development Manager , Ferrer Internacional S. A., Jun 17

Very useful and relevant discussions

David Ward, Senior Formulation Scientist, Intertek, Jun 17

Overall I thought that the course was very useful, mainly due to the networking opportunities. The breadth of attendees was great to get wider conversations underway and broaden understanding. The scientific talks were generally excellent, and although some other talks were more around promoting products / services, the overall impression was positive and useful.

Richard Poole, Team Leader - Pharmaceutical Development, Vectura, Jun 17

One of the best courses I attended

Anna Giulia Balducci, Senior Scientist, Chiesi Limited, Jun 17

Great environment to stimulate debate! And challenge preconceptions and novel ideas

Richard Turner, Director Global Sales, Presspart Manufacturing Ltd, Jun 16

The course was very well organised, with a good selection of speakers and topics covered. I will certainly recommend future events to my colleagues.

Christopher Vernall, Business Development Director, Intertek Melbourn, Jun 16

Very good and useful update. Clear messages coming through.

Simon Strothers, Director, 3P Innovation Ltd, Jun 16

The course contained a good mix of speakers, the talks were current and relevant, the speakers responded well to lively discussions and challenges from the delegates. This is a good size meeting with questions freely asked and delegate interaction very high.

Tanya Church, Head of Laboratory, Chiesi Limited, Jun 16